|
DE2947526A1
(de)
|
1978-11-29 |
1980-06-12 |
Ono Pharmaceutical Co |
Prostacyclin-analoge
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
JPS61289034A
(ja)
|
1985-06-17 |
1986-12-19 |
Teijin Ltd |
イソカルバサイクリン類脂肪乳剤
|
|
US4837342A
(en)
|
1986-02-28 |
1989-06-06 |
Sagami Chemical Research Center |
Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
GB9011588D0
(en)
|
1990-05-24 |
1990-07-11 |
Wellcome Found |
Prostaglandin analogues for use in medicine
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5190972A
(en)
|
1992-01-27 |
1993-03-02 |
The University Of Melbourne |
Method of combatting cyclosporine organ toxicity with prostaglandin analogs
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
US6441245B1
(en)
|
1997-10-24 |
2002-08-27 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
EP1045695B1
(en)
|
1997-11-14 |
2004-03-24 |
United Therapeutics Corporation |
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
|
|
AU742250B2
(en)
|
1997-12-26 |
2001-12-20 |
Astellas Pharma Inc. |
Sustained release medicinal compositions
|
|
JP2002521423A
(ja)
|
1998-07-31 |
2002-07-16 |
コリア インスティチュート オブ サイエンス アンド テクノロージ |
遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
|
|
US6265495B1
(en)
|
1998-09-22 |
2001-07-24 |
Nippon Shokubai Co., Ltd. |
Method for production of esterified product
|
|
US6521212B1
(en)
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
|
AU4327300A
(en)
|
1999-03-31 |
2000-10-16 |
United Therapeutics Corporation |
Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
|
US6991809B2
(en)
|
2001-06-23 |
2006-01-31 |
Lyotropic Therapeutics, Inc. |
Particles with improved solubilization capacity
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US6803386B2
(en)
|
2002-01-16 |
2004-10-12 |
United Therapeutics Corporation |
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
|
|
AU2003258075A1
(en)
|
2002-08-06 |
2004-02-23 |
Lyotropic Therapeutics, Inc. |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
US20050244503A1
(en)
|
2003-05-19 |
2005-11-03 |
Rabinow Barrett E |
Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
|
|
ES2272914T3
(es)
|
2003-05-20 |
2007-05-01 |
Ethypharm |
Composicion farmaceutica oral de liberacion sostenida.
|
|
CA2959852A1
(en)
|
2003-05-22 |
2005-01-27 |
United Therapeutics Corporation |
Compounds and methods for delivery of prostacyclin analogs
|
|
US8765813B2
(en)
|
2003-12-16 |
2014-07-01 |
United Therapeutics Corporation |
Use of treprostinil to treat and prevent ischemic lesions
|
|
DE602004022982D1
(de)
|
2003-12-16 |
2009-10-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur verbesserung der nierenfunktion
|
|
WO2005099680A2
(en)
|
2004-04-12 |
2005-10-27 |
United Therapeutics, Inc. |
Use of treprostinil to treat neuropathic diabetic foot ulcers
|
|
GB0416328D0
(en)
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
CA2574958A1
(en)
|
2004-07-26 |
2006-02-09 |
Cotherix, Inc. |
Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
|
|
EP1806148A4
(en)
|
2004-10-22 |
2009-12-02 |
Ono Pharmaceutical Co |
THERAPEUTIC PREPARATION FOR INHALATION
|
|
JP2009519972A
(ja)
|
2005-12-15 |
2009-05-21 |
アキュスフィア， インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
|
KR101390579B1
(ko)
|
2006-05-15 |
2014-05-19 |
유나이티드 세러퓨틱스 코오포레이션 |
정량 흡입기를 사용한 트레프로스티닐 투여
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
CN102648916A
(zh)
|
2007-02-09 |
2012-08-29 |
联合治疗公司 |
用于间质性肺病和哮喘的曲前列尼治疗
|
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
POLY (AMINIC ACID) TARGET MOLECULES
|
|
KR101693049B1
(ko)
|
2007-09-07 |
2017-01-04 |
유나이티드 세러퓨틱스 코오포레이션 |
그람 음성 박테리아에 대한 선택적인 살균 활성을 갖는 완충 용액 및 이의 이용방법
|
|
EP2252570B1
(en)
|
2007-12-17 |
2017-04-05 |
United Therapeutics Corporation |
An improved process to prepare treprostinil, the active ingredient in remodulin ®
|
|
KR20110010753A
(ko)
|
2008-05-08 |
2011-02-07 |
유나이티드 세러퓨틱스 코오포레이션 |
트레프로스티닐 일수화물
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
WO2009158010A1
(en)
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Prostacyclin analogs
|
|
WO2010039531A1
(en)
|
2008-09-23 |
2010-04-08 |
Resolvyx Pharmaceuticals, Inc. |
Therapeutic compounds
|
|
EP2330893A4
(en)
|
2008-09-25 |
2013-01-09 |
Aradigm Corp |
DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL
|
|
CA2749352A1
(en)
|
2009-02-20 |
2010-09-10 |
Micro Labs Limited |
Storage stable prostaglandin product
|
|
KR101544246B1
(ko)
|
2009-05-07 |
2015-08-12 |
유나이티드 세러퓨틱스 코오포레이션 |
프로스타시클린 유사체의 고체 제제
|
|
WO2011005505A2
(en)
|
2009-06-22 |
2011-01-13 |
Johnson Matthey Public Limited Company |
Method for the purification of prostaglandins
|
|
US20120270934A1
(en)
|
2009-07-03 |
2012-10-25 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
BR112012002578B8
(pt)
|
2009-08-07 |
2021-05-25 |
Scipharm Sarl |
usos de treprostinil ou de um derivado ou de um sal farmaceuticamente aceitável do mesmo para tratamento da fibrose cística
|
|
PH12012500360A1
(en)
|
2009-08-21 |
2019-07-10 |
Targeted Delivery Tech Limited |
Vesicular formulations
|
|
CN101669904B
(zh)
|
2009-09-29 |
2011-06-22 |
北京中海康医药科技发展有限公司 |
一种依前列醇脂质纳米粒及制备方法
|
|
WO2011089216A1
(en)
|
2010-01-22 |
2011-07-28 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
|
EP2525829A1
(en)
|
2010-01-22 |
2012-11-28 |
Ascendis Pharma A/S |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
CN102883722B
(zh)
|
2010-03-15 |
2014-11-05 |
联合治疗公司 |
用于肺动脉高血压的治疗
|
|
EP2576492B1
(en)
|
2010-06-03 |
2017-09-20 |
United Therapeutics Corporation |
Treprostinil production
|
|
US20120004307A1
(en)
|
2010-06-15 |
2012-01-05 |
United Therapeutics Corporation |
Oral treatment of digital ischemic lesions
|
|
US20120010159A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
JP5780775B2
(ja)
|
2011-02-18 |
2015-09-16 |
株式会社Ｌｔｔバイオファーマ |
プロスタグランジンｉ２誘導体を含有するナノ粒子
|
|
JP5580491B2
(ja)
|
2011-03-02 |
2014-08-27 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニル製造のための中間体の合成
|
|
WO2012124688A1
(ja)
|
2011-03-14 |
2012-09-20 |
国立大学法人北海道大学 |
肺送達のためのベクター、導入剤及び使用
|
|
CN103874480A
(zh)
|
2011-08-12 |
2014-06-18 |
阿森迪斯药物股份有限公司 |
前列环素的缓释组合物
|
|
EP2741782B1
(en)
|
2011-08-12 |
2020-05-06 |
Ascendis Pharma A/S |
Protein carrier-linked prodrugs
|
|
HK1198359A1
(en)
|
2011-08-12 |
2015-04-10 |
Ascendis Pharma A/S |
Carrier-linked treprostinil prodrugs
|
|
EP2741779A1
(en)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
CA2843503C
(en)
|
2011-08-12 |
2020-12-22 |
Ulrich Hersel |
Polymeric hyperbranched carrier-linked prodrugs
|
|
WO2013024053A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
PL2674413T3
(pl)
|
2012-06-15 |
2018-05-30 |
Scipharm Sàrl |
Sposób wytwarzania treprostynilu i jego pochodnych
|
|
IN2015DN00934A
(OSRAM)
|
2012-08-01 |
2015-06-12 |
United Therapeutics Corp |
|
|
EP2879684B1
(en)
|
2012-08-01 |
2019-01-30 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
|
|
KR20150089087A
(ko)
|
2012-11-30 |
2015-08-04 |
인스메드 인코포레이티드 |
프로스타사이클린 조성물 및 이를 이용하기 위한 방법
|
|
ES2697573T3
(es)
|
2013-01-09 |
2019-01-25 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
|
EP3712142B1
(en)
*
|
2013-01-11 |
2022-07-06 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
CA3212313A1
(en)
|
2013-03-14 |
2014-10-02 |
United Therapeutics Corporation |
Solid forms of treprostinil
|
|
CN109608326A
(zh)
|
2013-03-15 |
2019-04-12 |
联合治疗公司 |
曲前列环素的盐
|
|
CA2908244C
(en)
|
2013-03-25 |
2021-04-20 |
United Therapeutics Corporation |
Process of making prostacyclin compounds with linker thiol and pegylated forms
|
|
CA2911172C
(en)
|
2013-04-30 |
2021-10-19 |
United Therapeutics Corporation |
Controlled release pharmaceutical formulations
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
JP6483714B2
(ja)
|
2013-10-11 |
2019-03-13 |
ローレンス エス． ジスマン， |
噴霧乾燥製剤
|
|
BR112016009207B1
(pt)
|
2013-10-25 |
2022-11-22 |
Insmed Incorporated |
Compostos de prostaciclina
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
JP2017517550A
(ja)
|
2014-06-13 |
2017-06-29 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニル製剤
|
|
EP3209415B1
(en)
|
2014-10-20 |
2020-02-19 |
United Therapeutics Corporation |
Synthesis of intermediates for producing prostacyclin derivatives
|
|
CA2967385C
(en)
|
2014-11-18 |
2023-05-16 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
|
US20160318844A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
IL262720B2
(en)
|
2016-05-05 |
2024-06-01 |
Liquidia Tech Inc |
Dry powder treprostinil for the treatment of pulmonary hypertension
|
|
WO2017223400A1
(en)
|
2016-06-24 |
2017-12-28 |
Insmed Incorporated |
Prostacyclin compounds and compositions for treating sarcoidosis
|
|
EP3515430A1
(en)
|
2016-09-26 |
2019-07-31 |
United Therapeutics Corporation |
Treprostinil prodrugs
|
|
EP3673895A1
(en)
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
KR20220002600A
(ko)
|
2019-04-29 |
2022-01-06 |
인스메드 인코포레이티드 |
트레프로스티닐 전구약물의 건조 분말 조성물 및 이의 사용 방법
|